Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam + remifentanil versus propofol + remifentanil for laryngeal mask insertion
ChiCTR2100052136Phase 4Not yet recruiting
- Sponsor
- Renmin Hospital of Wuhan University
- Start
- Jan 2022
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of remimazolam, remifentanil and propofol (2 arms), sponsored by Renmin Hospital of Wuhan University. Primary endpoint: Muzi Score System while inserting laryngeal mask. Planned start Jan 2022; status: not yet recruiting.
02
Drugs
remimazolamremifentanilpropofol
Beyond the preview
Go deeper on ChiCTR2100052136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100052136.